Thanks to the 200,000 doses from the Chinese laboratory Sinopharm, Senegal can officially launch its vaccination campaign against Covid-19 on Tuesday February 23. Yesterday Saturday, the Minister of Health chaired the deployment of the Chinese product in the regions.
Shaken by a second deadlier wave of the coronavirus, Senegal has decided to step up the pace and is committed to vaccinating at least 20% of its population by the end of 2021.
The vaccine deployment plan drawn up by the Prevention Department at the Ministry of Health gave details of the target groups, in particular health personnel (20,668; 0.12%), those aged 60 and over without comorbidities (447 811; 2.6%), 60 years and over with comorbidities (516,705; 3%) and 19-60 years with comorbidity (2,445,736; 14.2%). That is, a total of 3,430,920 people to be vaccinated initially.
But given the timidity of the first acquisition, health personnel and front-line agents will be the first beneficiaries, specifies the Director of Prevention to our colleagues from the German newspaper Bloomberg.
The pace will accelerate in March with the arrival of the doses expected from the Covax initiative. In this device launched in June 2020 to help underdeveloped countries, Senegal should be entitled to at least 1.3 million of the product developed by the AstraZeneca laboratory in collaboration with the University of Oxford. But it will be licensed by Serum Institute of India (SII).
According to Dr Mamadou Ndiaye, these doses are expected in the first week of March.
On its website, the Vaccine Alliance, one of the organizations that pilot this facility with WHO, had announced that the first deliveries should be made towards the end of February.
On the occasion of receiving the Chinese vaccine, the President of the Republic announced the imminent arrival of 6.7 million doses from other manufacturers. The advisory committee for vaccination in Senegal has validated five vaccines against Covid-19.
#AstraZeneca #vaccine #expected #week #March